Dr. Brufsky on Trastuzumab and Eribulin for HER2+ Metastatic Breast Cancer

Adam M. Brufsky, MD, PhD, professor of medicine, associate chief, Division of Hematology/Oncology, University of Pittsburgh, discusses the results of a phase II study that looked at the effect of prio... Author: onclivetv Added: 07/16/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts